UK Subscription Contracts Will Target Antimicrobials Against ‘Critical’ Pathogens
Pharma companies seeking a subscription-style contract for new antimicrobials will need to meet a number of requirements, such as guaranteeing surety of supply, meeting key performance measures and complying with specified manufacturing standards.
